Aranesp and Feraheme drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aranesp (darbepoetin alfa) and Feraheme (ferumoxytol). Common drug interactions include infection among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Aranesp and Feraheme. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

What is Feraheme?

Feraheme has active ingredients of ferumoxytol. eHealthMe is studying from 1,884 Feraheme users. Check the latest studies of Feraheme.

On Jul, 12, 2026

30 people who take Aranesp and Feraheme together, and have interactions are studied.

What are the common drug interactions of Aranesp and Feraheme, by gender? *:

female:

Infection
Infectious peritonitis (inflammation of the peritoneum, typically caused by bacterial infection)
Iron deficiency anaemia
Post procedural haemorrhage (post procedural bleeding)
Pyrexia (fever)
Urine flow decreased
Urine output decreased
Weight increased
Anaphylactic reaction (serious allergic reaction)
Arthralgia (joint pain)

male:

Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Abdominal pain
Diarrhoea
Dizziness
Feeling cold
Haemoglobin decreased
Hyperhidrosis (abnormally increased sweating)
Anxiety
Aortic valve sclerosis (narrowing of the aortic valve)

What are the common drug interactions of Aranesp and Feraheme, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaphylactic reaction (serious allergic reaction)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Infusion site urticaria (rash of round, red welts on the skin at infusion site)
Pallor

40-49:

Abdominal distension
Catheter site erosion
Catheter site swelling
Generalised oedema (swelling all over the body)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Infection
Infectious peritonitis (inflammation of the peritoneum, typically caused by bacterial infection)
Iron deficiency anaemia
Nausea (feeling of having an urge to vomit)
Post procedural haemorrhage (post procedural bleeding)

50-59:

Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Hypotension (abnormally low blood pressure)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased
Pleural effusion (water on the lungs)
Vomiting
Wheezing (a high-pitched whistling sound made while you breath)
Anaphylactic reaction (serious allergic reaction)

60+:

Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
Anti-erythropoietin antibody positive
Hypotension (abnormally low blood pressure)
Unresponsive to stimuli
Cardiac arrest
Dizziness
Flushing (the warm, red condition of human skin)
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased
Vomiting

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 7 people, 23.33%
Chronic Renal Failure (kidney failure): 7 people, 23.33%
Iron Deficiency: 5 people, 16.67%
Anaemia (lack of blood): 5 people, 16.67%
Acute Kidney Failure: 5 people, 16.67%
Nephrogenic Anaemia (anaemia due to kidney disease): 3 people, 10.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 10.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.00%
Hyperkalemia (damage to or disease of the kidney): 3 people, 10.00%
Heart Disease: 3 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and Feraheme?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously